125 related articles for article (PubMed ID: 32572940)
1. CHCHD2 decreases docetaxel sensitivity in breast cancer via activating MMP2.
Ma L; Zheng LH; Zhang DG; Fan ZM
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6426-6433. PubMed ID: 32572940
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells.
Zhao G; Li Y; Wang T
Biochem Biophys Res Commun; 2017 May; 487(2):255-261. PubMed ID: 28412359
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
4. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells.
Alkhatib MH; Bawadud RS; Gashlan HM
Sci Rep; 2020 Oct; 10(1):18124. PubMed ID: 33093596
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
8. Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer.
Zhang J; Meng H; Zhang M; Zhang C; Huang M; Yan C; Wang Z; Hou L; Yang L; Ling R
Endocr Relat Cancer; 2020 May; 27(5):309-323. PubMed ID: 32203934
[TBL] [Abstract][Full Text] [Related]
9. AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.
Li J; Guo Y; Duan L; Hu X; Zhang X; Hu J; Huang L; He R; Hu Z; Luo W; Tan T; Huang R; Liao D; Zhu YS; Luo DX
Oncotarget; 2017 May; 8(20):33694-33703. PubMed ID: 28402270
[TBL] [Abstract][Full Text] [Related]
10. Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent.
Batista de Carvalho AL; Medeiros PS; Costa FM; Ribeiro VP; Sousa JB; Diniz C; Marques MP
PLoS One; 2016; 11(11):e0167218. PubMed ID: 27880824
[TBL] [Abstract][Full Text] [Related]
11. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles with Optimal Ratiometric Co-Delivery of Docetaxel with Gambogic Acid for Treatment of Multidrug-Resistant Breast Cancer.
Xu Y; Wang C; Ding Y; Wang Y; Liu K; Tian Y; Gao M; Li Z; Zhang J; Li L
J Biomed Nanotechnol; 2016 Sep; 12(9):1774-81. PubMed ID: 29345888
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.
Yan M; Wang J; Ren Y; Li L; He W; Zhang Y; Liu T; Li Z
Cell Death Dis; 2019 Feb; 10(3):204. PubMed ID: 30814489
[TBL] [Abstract][Full Text] [Related]
14. DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel.
Yang X; Liu Y; Li W; Li A; Sun Q
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):899-906. PubMed ID: 28981599
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
16. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
Poudel I; Ahiwale R; Pawar A; Mahadik K; Bothiraja C
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):229-240. PubMed ID: 29575931
[TBL] [Abstract][Full Text] [Related]
17. A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1.
Ming J; Ruan S; Wang M; Ye D; Fan N; Meng Q; Tian B; Huang T
Oncotarget; 2015 Dec; 6(38):40692-703. PubMed ID: 26517687
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy.
Swetha KL; Sharma S; Chowdhury R; Roy A
Pharmacol Rep; 2020 Dec; 72(6):1749-1765. PubMed ID: 32617902
[TBL] [Abstract][Full Text] [Related]
19. MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
Yang F; Luo LJ; Zhang L; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
Gene; 2017 Feb; 600():21-28. PubMed ID: 27913185
[TBL] [Abstract][Full Text] [Related]
20. Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization.
Sheng D; Ma W; Zhang R; Zhou L; Deng Q; Tu J; Chen W; Zhang F; Gao N; Dong M; Wang D; Li F; Liu Y; He X; Duan S; Zhang L; Liu T; Liu S
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35613826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
